Providing Test Services to Better Understand COVID-19 Immune Response

Broadly deployed high-performance antibody tests are critical to success.

ProterixBio is collaborating with leading research institutions to provide COVID-19 serological testing that has the combined benefits of convenient finger prick sample collection and high-performance laboratory-based assays. These products are critical for on-going disease research, vaccine and therapeutic development, public health surveillance and back-to-work programs.

ProterixBio’s products enable organizations to broadly deploy the highest quality antibody tests to support decision making.

Antibody Testing

Playing an Important Role in COVID-19
Public Health and Back-to-Work Surveillance Programs

For COVID-19, antibody testing is an important complement to viral testing. Active infections are diagnosed using nucleic acid tests that detect viral particles in samples from the respiratory tract or saliva. Antibodies, which are detected in the blood, provide confirmation of prior infection and may indicate a level of immunity to re-infection.

Antibody tests are needed to track the overall rate of increase of COVID-19 cases since viral tests only identify active infections. This includes identifying asymptomatic cases and potential transmission paths. Antibody tests can also help confirm cases that were missed by viral testing.

Antibody testing is an essential element to COVID-19 programs that seek to comprehensively protect the health of an organization’s members.

About ProterixBio

ProterixBio develops and commercializes diagnostic solutions that address critical unmet needs in population health and chronic care. An area of focus has been vulnerable populations such as those with chronic obstructive pulmonary disease, diabetes and cardiovascular disease. The company has developed algorithms utilizing combinations of blood-based biomarkers for identifying individuals at high risk for severe outcomes. ProterixBio maintains a rigorous approach to test development that includes collaborating with leading academic medical centers and validating assays in large, carefully curated cohorts. ProterixBio is headquartered and operates a laboratory in Billerica, MA.

Learn more about ProteriBio

Latest Updates

Press Releases View All

For more information: